文献速递生殖医学

氯米芬促排卵宫腔内人工授精周期中hCG触发的最佳主导卵泡大小:1676个周期的分析

Optimal lead follicle size for human chorionic gonadotropin trigger in clomiphene citrate and intrauterine insemination cycles: an analysis of 1,676 treatment cycles.
PubMed 文献 · Fertil Steril · 2020-12-04

这项回顾性队列研究纳入1676个首次氯米芬-宫腔内人工授精(CC-IUI)周期,分析主导卵泡大小与临床妊娠率的关系。总体临床妊娠率为13.8%(232/1676)。与主导卵泡19.1-20.0 mm相比,21.1-22.0 mm和>22.0 mm的临床妊娠 odds 分别高2.3倍和2.2倍;主导卵泡22.1 mm对应敏感度80.1%、特异度90.4%,ROC曲线下面积0.89。结论:在21.1-22.0 mm给予hCG与更高的临床妊娠 odds 相关。

要点

  • 首次CC-IUI周期中,主导卵泡21.1-22.0 mm时hCG触发与更高临床妊娠 odds 相关。
  • 主导卵泡22.1 mm对临床妊娠的敏感度80.1%、特异度90.4%,AUC 0.89。
  • 总体临床妊娠率13.8%(232/1676),主导卵泡大小是独立预测因素。

核心结论

  • 对于因排卵功能障碍或不明原因不孕接受首次CC-IUI周期的患者,在主导卵泡21.1-22.0 mm时给予hCG与更高的临床妊娠 odds 相关。

研究设计与样本

  • 回顾性队列研究,纳入1676个首次CC-IUI周期,患者年龄<40岁,因排卵功能障碍或不明原因不孕接受促排卵、hCG触发和IUI。

主要发现

  • 总体临床妊娠率为13.8%(232/1676)。
  • 与主导卵泡19.1-20.0 mm相比,21.1-22.0 mm和>22.0 mm的临床妊娠 odds 分别高2.3倍和2.2倍。
  • 主导卵泡大小是临床妊娠率的独立预测因素,即使校正混杂因素后。
  • 主导卵泡22.1 mm对应临床妊娠的敏感度80.1%、特异度90.4%,ROC曲线下面积0.89。

关键数值与推荐

  • 主导卵泡21.1-22.0 mm时hCG触发与更高的临床妊娠 odds 相关(OR 2.3,95%CI未报告)。
  • 主导卵泡>22.0 mm时hCG触发与更高的临床妊娠 odds 相关(OR 2.2,95%CI未报告)。
  • 主导卵泡22.1 mm对临床妊娠的敏感度80.1%、特异度90.4%,AUC 0.89。

临床怎么用

  • 在首次CC-IUI周期中,可考虑在主导卵泡达到21.1-22.0 mm时给予hCG触发以优化临床妊娠机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the optimal lead follicle size for hCG trigger in clomiphene citrate (CC)-intrauterine insemination (IUI) cycles. DESIGN: Retrospective cohort study. SETTING: University-affiliated center. PATIENT(S): Patients <40 years of age with ovulatory dysfunction or unexplained infertility undergoing their first CC-IUI cycle. INTERVENTION(S): Ovulation induction, hCG trigger, and IUI. MAIN OUTCOME MEASURE(S): Clinical pregnancy rate (CPR) was the primary outcome and was plotted against lead follicle size in increments of 1 mm. Odds ratios with 95% confidence intervals for associations between lead follicle size and CPR were calculated from a multivariable logistic regression model. A receiver operating characteristic (ROC) curve was generated for CPR as a function of lead follicle size. RESULT(S): 1,676 cycles were included. The overall CPR was 13.8% (232/1,676). There was no difference in baseline demographics or ovulation induction parameters of patients who did or did not conceive. The odds of clinical pregnancy were 2.3 and 2.2 times higher with lead follicle sizes of 21.1-22.0 mm and >22.0 mm, respectively, compared with the referent category of 19.1-20.0 mm. Lead follicle size was an independent predictor of CPR, even after accounting for confounders. A lead follicle size of 22.1 mm corresponded to a sensitivity and specificity of 80.1% and 90.4% for clinical pregnancy, respectively, with an area under the ROC curve of 0.89. CONCLUSION(S): hCG administration at a lead follicle size of 21.1-22.0 mm is associated with higher odds of clinical pregnancy in patients undergoing their first CC-IUI cycles for ovulatory dysfunction or unexplained infertility.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Hancock KL, Pereira N, Christos PJ, et al. Optimal lead follicle size for human chorionic gonadotropin trigger in clomiphene citrate and intrauterine insemination cycles: an analysis of 1,676 treatment cycles. Fertil Steril. 2020. PMID: 33272641. doi:10.1016/j.fertnstert.2020.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。